Stanley-Laman Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,970
Closed -$990K 306
2019
Q3
$990K Sell
9,970
-862
-8% -$85.6K 0.24% 132
2019
Q2
$1M Buy
10,832
+368
+4% +$34K 0.24% 134
2019
Q1
$987K Buy
10,464
+517
+5% +$48.8K 0.24% 131
2018
Q4
$638K Sell
9,947
-371
-4% -$23.8K 0.18% 200
2018
Q3
$923K Sell
10,318
-53
-0.5% -$4.74K 0.23% 134
2018
Q2
$824K Buy
10,371
+811
+8% +$64.4K 0.19% 162
2018
Q1
$853K Buy
9,560
+130
+1% +$11.6K 0.19% 147
2017
Q4
$984K Buy
+9,430
New +$984K 0.21% 131
2017
Q1
Sell
-11,602
Closed -$1.34M 305
2016
Q4
$1.34M Buy
11,602
+1,246
+12% +$144K 0.42% 89
2016
Q3
$1.08M Buy
10,356
+1,248
+14% +$131K 0.44% 66
2016
Q2
$898K Buy
+9,108
New +$898K 0.35% 107
2016
Q1
Sell
-11,542
Closed -$1.38M 378
2015
Q4
$1.38M Buy
11,542
+1,325
+13% +$159K 0.24% 115
2015
Q3
$1.11M Buy
10,217
+346
+4% +$37.4K 0.22% 113
2015
Q2
$1.14M Buy
9,871
+581
+6% +$67.2K 0.21% 121
2015
Q1
$1.07M Buy
9,290
+1,261
+16% +$145K 0.2% 127
2014
Q4
$898K Buy
8,029
+1,338
+20% +$150K 0.17% 139
2014
Q3
$634K Buy
6,691
+419
+7% +$39.7K 0.12% 169
2014
Q2
$539K Buy
+6,272
New +$539K 0.1% 200